Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Year-over-year book value per share growth
5Y CAGR
+13.2%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 15.85% |
| 2024 | 12.05% |
| 2023 | 14.39% |
| 2022 | -28.27% |
| 2021 | 12.64% |
| 2020 | 8.53% |
| 2019 | 73.16% |
| 2018 | 17.18% |
| 2017 | 11.81% |
| 2016 | 15.75% |